50 results on '"Dong, Seung-Myung"'
Search Results
2. Association of CHFR Promoter Methylation with Treatment Outcomes of Irinotecan-Based Chemotherapy in Metastatic Colorectal Cancer
3. Specific protein 1(SP1) regulates the epithelial-mesenchymal transition via lysyl oxidase-like 2(LOXL2) in pancreatic ductal adenocarcinoma
4. A key axis of the N-WASP signaling pathway promotes distant metastasis in pancreatic cancer: LOXL2-FAK-N-WASP
5. Hypermethylation of the interferon regulatory factor 5 promoter in Epstein-Barr virus-associated gastric carcinoma
6. Frequent promoter hypermethylation of TGFBI in epithelial ovarian cancer
7. Pre-Clinical Pharmacokinetic Characterization, Tissue Distribution, and Excretion Studies of Novel Edaravone Oral Prodrug, TEJ-1704
8. Natural history of persistent high-risk human papillomavirus infections in Korean women
9. LOXL2 expression is associated with invasiveness and negatively influences survival in breast cancer patients
10. Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells
11. FAS −1377 G/A polymorphism and the risk of lymph node metastasis in cervical cancer
12. Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer
13. A simple, precise and economical microdissection technique for analysis of genomic DNA from archival tissue sections
14. Prognostic significance of c-Met expression in glioblastomas
15. Insulin-like growth factor-binding protein-5 (IGFBP-5) acts as a tumor suppressor by inhibiting angiogenesis
16. RASSF1A hypermethylation and its inverse correlation with BRAF and/or KRAS mutations in MSI-associated endometrial carcinoma
17. Detecting Colorectal Cancer in Stool With the Use of Multiple Genetic Targets
18. Immunohistochemical analysis of Fas ligand expression in normal human tissues
19. Alterations of Fas (Apo-1/CD95) Gene in Cutaneous Malignant Melanoma
20. Cellular inhibitor of apoptosis protein 2 promotes the epithelial-mesenchymal transition in triple-negative breast cancer cells through activation of the AKT signaling pathway
21. Role of LOXL2 in the epithelial-mesenchymal transition and colorectal cancer metastasis
22. Emerging role of LOXL2 in the promotion of pancreas cancer metastasis
23. Regulation of HK2 expression through alterations in CpG methylation of the HK2 promoter during progression of hepatocellular carcinoma
24. Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation
25. Identification of occult tumors by whole-specimen mapping in solitary papillary thyroid carcinoma
26. Standardized uptake value of 18F-fluorodeoxyglucose positron emission tomography for prediction of tumor recurrence in breast cancer beyond tumor burden
27. Lysyl oxidase-like 2 (LOXL2) controls tumor-associated cell proliferation through the interaction with MARCKSL1
28. GABARBP down-regulates HIF-1α expression through the VEGFR-2 and PI3K/mTOR/4E-BP1 pathways
29. The antihypertension drug doxazosin inhibits tumor growth and angiogenesis by decreasing VEGFR-2/Akt/mTOR signaling and VEGF and HIF-1α expression
30. Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2/PI3K/mTOR pathway in ovarian cancer xenografts
31. Tumor suppressor BLU promotes paclitaxel antitumor activity by inducing apoptosis through the down-regulation of Bcl-2 expression in tumorigenesis
32. Anti-angiogenic effects of thioridazine involving the FAK-mTOR pathway
33. Tumor suppressor BLU enhances pro-apoptotic activity of sMEK1 through physical interaction
34. Prognostic significance of c-Met expression in glioblastomas
35. The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization
36. Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma
37. Characterization of a Human Homologue of Proteolysis-Inducing Factor and Its Role in Cancer Cachexia
38. Detecting Cervical Cancer by Quantitative Promoter Hypermethylation Assay on Cervical Scrapings: A Feasibility Study
39. Methylation status in the promoter region of the human PGP9.5 gene in cancer and normal tissues
40. Molecular detection of cervical intraepithelial neoplasia and cervical carcinoma by microsatellite analysis of Papanicolaou smears
41. Detection of p16 gene alteration in cervical cancer using tissue microdissection and LOH study
42. Genetic Alterations ofp16INK4aandp53Genes in Sporadic Dysplastic Nevus
43. Phase II trial of low-dose continuous (metronomic) treatment of temozolomide for recurrent glioblastoma.
44. Alterations of Fas(Apo-1/CD95) Gene in Cutaneous Malignant Melanoma
45. Standardized uptake value of ¹⁸F-fluorodeoxyglucose positron emission tomography for prediction of tumor recurrence in breast cancer beyond tumor burden.
46. Epigenetic inactivation of RASSF1A in head and neck cancer.
47. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
48. DeltaNp63alpha and TAp63alpha regulate transcription of genes with distinct biological functions in cancer and development.
49. Absence of ST7 gene alterations in human cancer.
50. Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.